These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9579879)

  • 1. The estimation of efficacy of oral iron supplementation during treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing cardiac surgery.
    Sowade O; Messinger D; Franke W; Sowade B; Scigalla P; Warnke H
    Eur J Haematol; 1998 Apr; 60(4):252-9. PubMed ID: 9579879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of reticulocyte maturity fractions and indices and iron status during therapy with epoetin beta (recombinant human erythropoietin) in cardiac surgery patients.
    Sowade O; Sowade B; Brilla K; Franke W; Stephan P; Gross J; Scigalla P; Warnke H
    Am J Hematol; 1997 Jun; 55(2):89-96. PubMed ID: 9209004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of erythropoietic activity on the basis of the red cell and reticulocyte distribution widths during epoetin beta therapy in patients undergoing cardiac surgery.
    Sowade O; Sowade B; Gross J; Brilla K; Ziemer S; Franke W; Stephan P; Scigalla P; Warnke H
    Acta Haematol; 1998; 99(1):1-7. PubMed ID: 9490558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery.
    Sowade O; Warnke H; Scigalla P; Sowade B; Franke W; Messinger D; Gross J
    Blood; 1997 Jan; 89(2):411-8. PubMed ID: 9002942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous versus oral iron supplementation for preoperative stimulation of hemoglobin synthesis using recombinant human erythropoietin.
    Rohling RG; Zimmermann AP; Breymann C
    J Hematother Stem Cell Res; 2000 Aug; 9(4):497-500. PubMed ID: 10982248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy.
    Biesma DH; Van de Wiel A; Beguin Y; Kraaijenhagen RJ; Marx JJ
    Eur J Clin Invest; 1994 Jun; 24(6):426-32. PubMed ID: 7957497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response.
    Rutherford CJ; Schneider TJ; Dempsey H; Kirn DH; Brugnara C; Goldberg MA
    Am J Med; 1994 Feb; 96(2):139-45. PubMed ID: 8109598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The perioperative use of recombinant erythropoietin (rhEPO) in Jehovah's witnesses].
    Soukup J; Menzel M; Roth S; Radke J
    Anaesthesist; 1996 Aug; 45(8):745-9. PubMed ID: 8967587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
    Chiang WC; Tsai TJ; Chen YM; Lin SL; Hsieh BS
    Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of oxygen availability with oxygen status algorithm in patients undergoing open heart surgery treated with epoetin beta.
    Sowade O; Gross J; Sowade B; Warnke H; Franke W; Messinger D; Scigalla P; Lun A; Glatzel E
    J Lab Clin Med; 1997 Jan; 129(1):97-105. PubMed ID: 9011596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial.
    Feagan BG; Wong CJ; Kirkley A; Johnston DW; Smith FC; Whitsitt P; Wheeler SL; Lau CY
    Ann Intern Med; 2000 Dec; 133(11):845-54. PubMed ID: 11103054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
    Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA
    Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo-controlled trial.
    Olijhoek G; Megens JG; Musto P; Nogarin L; Gassmann-Mayer C; Vercammen E; Hayes-Licitra SA
    Transfusion; 2001 Jul; 41(7):957-63. PubMed ID: 11452166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of preoperative recombinant human erythropoietin therapy on platelets and hemostasis in patients undergoing cardiac surgery.
    Sowade O; Ziemer S; Sowade B; Franke W; Messinger D; Ziebell E; Scigalla P; Warnke H
    J Lab Clin Med; 1997 Mar; 129(3):376-83. PubMed ID: 9042823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake.
    Bechensteen AG; Hågå P; Halvorsen S; Liestøl K; Lindemann R; Whitelaw A; Tølløfsrud PA; Daae L; Thorstensen K; Sundal E
    Eur J Pediatr; 1997 Jan; 156(1):56-61. PubMed ID: 9007493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation on the feasibility of large-volume autologous red blood cells donation: A pilot trial in a small cohort of Chinese.
    Wu J; Chen G; Wang L; Wang P; Han Y; Yang L; Ouyang X
    J Clin Apher; 2023 Aug; 38(4):447-456. PubMed ID: 36950971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of recombinant human erythropoietin on autologous blood donation before open heart surgery.
    Schmoeckel M; Nollert G; Mempel M; Mempel W; Reichart B
    Thorac Cardiovasc Surg; 1993 Dec; 41(6):364-8. PubMed ID: 8128466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery.
    Madi-Jebara SN; Sleilaty GS; Achouh PE; Yazigi AG; Haddad FA; Hayek GM; Antakly MC; Jebara VA
    J Cardiothorac Vasc Anesth; 2004 Feb; 18(1):59-63. PubMed ID: 14973801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recombinant erythropoietin in autologous blood donation].
    von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
    Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
    Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
    Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.